KATHLEEN RASSLER: Open Payments
NPI 1477079291 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 30 payments from 6 companies in 2025. Trend: 2023 $1,306 · 2024 $580 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $190 |
| Ipsen Biopharmaceuticals, Inc | 1 | $103 |
| Gilead Sciences, Inc. | 3 | $70 |
| Medtronic, Inc. | 1 | $34 |
| Fresenius Kabi USA, LLC | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: IQIRVO, LINZESS, BARRX, CREON, SKYRIZI, XIFAXAN, RINVOQ, VIBERZI.
Industry payments across RI — which companies pay providers there.
